Educational Activities

This CME Outfitters livestream symposium equips family medicine clinicians with practical, workflow-ready strategies to recognize and manage CKM disease as a unified continuum. In this activity, participants will explore the shared pathophysiology linking cardiovascular, kidney, and metabolic disease; sharpen their use of combined eGFR and uACR screening and KDIGO risk stratification; and apply guideline-aligned, patient-centered approaches that include shared decision-making and multidisciplinary coordination to optimize cardiorenal protection across overlapping comorbidities.

Obesity is transforming the landscape of inflammatory bowel disease (IBD), shaping disease activity, treatment response, and long-term prognosis. As evidence reveals the impact of excess weight on biologic and JAK inhibitor effectiveness, emerging anti-obesity therapies, including GLP-1 receptor agonists, are creating new opportunities to improve patient outcomes. To stay ahead of this rapidly evolving field, gastroenterologists and multidisciplinary care teams need timely, evidence-based education to confidently integrate obesity management into personalized, stigma-free IBD care.

This fast-paced and highly interactive livestream CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how the immunometabolic impact of visceral and mesenteric adiposity on disease activity, treatment response, and surgical risk translates into practice, what doesn’t translate, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply validated adiposity assessment methods, confidently integrate GLP-1 RAs into individualized treatment planning, and deliver patient-centered IBD care.

This event is neither sponsored by nor endorsed by ACG. 

This fast-paced and highly interactive live CaseWise™ webcast from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will explore key clinical challenges to help sharpen diagnostic confidence, individualize treatment, and help patients achieve better long-term outcomes.

In this CME Outfitters Engage the Experts recorded session, the community-based expert faculty from the Project ECHO® series will provide a comprehensive summary of key insights from the five-session CIDP Masterclass: Early Diagnosis, Emerging Options, Better Outcomes – A Project ECHO® Initiative series. Topics will include the clinical heterogeneity and pathophysiology of CIDP and the significance of immunoglobulin G (IgG) autoantibodies in its development, guideline-recommended diagnostic criteria to identify patients with CIDP, current and emerging treatment options including limitations of standard therapies and appropriate integration of novel agents into practice, and how to use collaborative care strategies to enhance long-term outcomes and quality of life for individuals with CIDP.

In the first activity of this CMEO Snack series, expert faculty will set the stage for the series: the biology of amylin, the promise of phenotype-guided care, and the emerging trial data that follow across three more expert conversations. Short, practical, and forward-looking — an essential primer for any clinician preparing for the next era of obesity care.

This fast-paced and highly interactive recorded CaseWise™ symposium from CME Outfitters will bring real-world clinical decision-making to life. Through dynamic patient cases, learners will compare their treatment choices to those of leading experts, peers in the room, providers in the community, patients themselves, and even AI-based insights. Learners will see how evidence translates into practice, what doesn’t, and why. Designed to challenge assumptions and sharpen strategy, this immersive format empowers clinicians to immediately apply guideline-recommended diagnostic criteria and comprehensive assessments into practice when there is clinical suspicion of IH to improve early and accurate diagnosis.